Larimar Therapeutics (LRMR) Other Gross PP&E Adjustments (2016 - 2020)
Historic Other Gross PP&E Adjustments for Larimar Therapeutics (LRMR) over the last 8 years, with Q3 2020 value amounting to -$4.0 million.
- Larimar Therapeutics' Other Gross PP&E Adjustments rose 4393.47% to -$4.0 million in Q3 2020 from the same period last year, while for Dec 2020 it was -$1.4 million, marking a year-over-year decrease of 490689.66%. This contributed to the annual value of $29000.0 for FY2019, which is 10084.16% up from last year.
- As of Q3 2020, Larimar Therapeutics' Other Gross PP&E Adjustments stood at -$4.0 million, which was up 4393.47% from -$3.9 million recorded in Q2 2020.
- In the past 5 years, Larimar Therapeutics' Other Gross PP&E Adjustments ranged from a high of $29000.0 in Q4 2019 and a low of -$7.3 million during Q2 2019
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was -$667000.0 (2016), whereas its average is -$2.2 million.
- The largest annual percentage gain for Larimar Therapeutics' Other Gross PP&E Adjustments in the last 5 years was 10084.16% (2019), contrasted with its biggest fall of 237310.34% (2019).
- Larimar Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$5.0 million in 2016, then grew by 10.19% to -$4.5 million in 2017, then rose by 23.96% to -$3.4 million in 2018, then surged by 100.84% to $29000.0 in 2019, then tumbled by 13965.52% to -$4.0 million in 2020.
- Its Other Gross PP&E Adjustments stands at -$4.0 million for Q3 2020, versus -$3.9 million for Q2 2020 and -$852000.0 for Q1 2020.